金捷生物科技股份有限公司GeneJet Biotech Co., Ltd.

CEO Hu Hsian Wei

Here we are!

OPR Team

Operation and Development

Chairman of Board/ 宣昶有

•Meridigen Biotech Co., Ltd

•Chairman of Meridigen Biotech Co., Ltd

Director of Board / 鄭忠政

•CEO of Bangsheng Obs Healthcare Co.,Ltd

Director of Board / 張紅淇

•CEO of Hungchi Hospital Medical Co.,Ltd

Managing Supervisor/ 詹婷怡

•Innovation consultant of Meridigen Biotech Co., Ltd

•Pre-Chairman of the National Communications Commission

CEO / 胡翔崴

•Doctoral Candidate in Biomedical Engineering, NCKU

•Co-founder of AcuSense BioMedical Technology Corp.

Chief Strategy Director / 鄭博仁

•Director of Gene Medicine Center,

CGMH

Consultant / 蔡光偉

•Director of Genetic Diagnosis Center,

CUHK

Consultant / 張舜智

•Director of Cytogenetics Center,

CGMH

Consultant / 蕭勝文

•Director of Fetal Treatment Center,

CGMH

International ISPD expert team

TECH Team

Purpose and mission

• Humanized Technology

• Everyday Gene

• Digitalized Health

• Instant Care

金：Transliteration of Gene in ChineseWe develop DNA-based testing products & services.

捷：JetOur products & services are equipped with POCT traits ; which means fast & precise.

Through minimalist process design and precise technological innovation, GeneJet POCT service model achieve convenient, fast care-end testing, immediate report, timely intervention care.

Non-nucleic acid extraction test kit + real-time fluorescent quantitative PCR instrument + digital reporting system! GeneJet POCT integrated set of overall output promote the care-end medical unit to a cutting-edge inspection center.

Service

Product

Product & Tech

POCT: Point of care tests

POCT care-end tests : Patients get sampled, examined, reported when seeking medical care

Free-nucleic acid extraction, One-

step inspection, instant report

Physician immediately follow the examine

report to perform precise medical

treatment and recommendations.

Traditional centralized tests : Patients get treatment at hospital, specimen is sent to the central laboratory or out-of-hospital centralized inspection center.

The patient gets initial treatment

and is taken of samples.

After the examination is done, the patient

make a return visit, and doctors provide

follow-up treatment according to reports.

TARGET Platform :TAiwanese Research for GEstational Technology

Product & Tech

GeneJet’s “Maternal and

Fetal Health Technology

implements home health

monitoring solutions”, R&D of

wearable devices for home

health monitoring during

pregnancy and childbirth,

data collection and AI

analysis APP, remote video

diagnosis and treatment

system, through extensive

collection and in-depth

analysis of maternal and child

health databases during

pregnancy and childbirth ,

practically used in the recent

epidemic prevention period.Asia & Silicon Valley teamed up GO SMART to demo the strength of Taiwan’s epidemic prevention technology

Healthcare industry covers clinical care,

medical device, and biotechnology

pharmaceutical. With the rising of genome,

big data, AI, digital healthcare and IOT, they

recreate the new face of healthcare mode

and research and development of medical

device.

our company seize the chance to import

innovation services, carry out novel R&D, so

that we grow steadily and continuously .

Industrial Link

Incubation of startupsBuilding a micro-health future city

GeneJet’s Visions

Healthcare industry covers clinical care,

medical device, and biotechnology

pharmaceutical. With the rising of genome,

big data, AI, digital healthcare and IOT, they

recreate the new face of healthcare mode

and research and development of medical

device.

our company seize the chance to import

innovation services, carry out novel R&D, so

that we grow steadily and continuously .

Industrial Link

GeneJet’s Visions

Form allianceConnecting the ecological

chain of the biomedical industry

Academic

Industry

Research

Chang Geng Hospital

Taipei City United Hospital

Industry-research-academic cooperation

Rapid analysis of drug metabolizing enzyme

genotypes, individualized drug evaluation, clinical

guidance on the selection of drug types and

dosages, and avoid drug-derived side effects and

comorbidities

Preventive Medicine/Solution

International market business strategy

Drug Genes/Solution

POCTFast．Precise．Convenient．Compatible

Traditional “out-of-hospital” or “centralized” test method

cannot match the clinical need of “Instant result, accurate

diagnosis, giving necessary treatment in time”.

Thus, GeneJet develops whole new omni-care of POCT

service mode, without complicated samples management.

Through a handy detector, it allows you to generate test

results at once, further speed up the reform of modern

medical treatment.

Chlamydia nucleic acid screening, to prevent maternal-

fetal infection; Hepatitis C nucleic acid detection, to

prevent maternal-fetal complications; Deafness drug

genetic testing, to avoid severe deafness in newborns

Maternal and Fetal Health/Solution

Child Health/Solution

Enterovirus nucleic acid detection, rapid report,

accurate classification, precise treatment; Noro,

rotatable, EB virus rapid analysis, differential

diagnosis, prevention of abusive antibiotics

Alcohol metabolism, obesity, hormonal drug

metabolism gene testing, etc., provide personalized,

all-round gene guidance.

International market business strategy Our Values

Devote in Taiwan．Spread across Asia Pacific．Vision the world

ⅠStart-up stage Ⅱ Intervention stage Ⅲ Promotion stage Ⅳ Growing stage

-Project developmentPrecise maternal fetal gene tests:-Expanding carrier gene examine-Prenatal familial high cholesterol gene detectionInstant maternal fetal infection tests:-Sepsis during pregnancy-Chlamydia infection-Hepatitis C infection

-Shareholder structure-GENEJET BIOMEDICAL TECHNOLOGY CO., LTD.-Taiwan KOL clinical Obstetrician and Gynecologist-The Network of TMFMS

-Social Media acknowledgement-Media exposure-Obstetrics and Gynecology Primary Clinic Platform-Physician re-education assistance promotion

-Replicate mode-Asia Pacific International Development-Other testing project development

Goal

Developmental Stage

Leaping Growth Mode

2021 Latest Product We designed the“IVF-Ovulation Induction Therapy AI Navigation

System”

Input: Patient background information + Blood test + Treatment doses

+AI algorithm & edge computing system

=Output: Predicted number of ovulations after the

treatment + best dose of medicine

2020.05.15Operation Team Gathering

2019.05.06

#Genejet Can Help

#Light of Taiwan Asia & Silicon Valley teamed upGO SMART to demo the strength of Taiwan’s epidemic prevention technology

2020.03.12

Invite representatives from industry, public associations & academia to participate in the

briefing session on innovative

medical services

2020.03.12Invite representatives from industry,

public associations & academia to

participate in the briefing session on innovative medical services

2020.02.12Sharing & exchange of business

information, epidemic situation, and

medical information between “GeneJet

Biotech” & “DIGITIMES” in the 5G world.

2019.12.27Director Lin Dingchao and Deputy

Director Yan Jixuan of the Youth Bureau

of Kaohsiung City led a delegation to

visit GeneJet Biotech Company!

2020.02.12

#Linkou Startup

terrace situation room

2019.12.27

#Taiwan Medical Expo

#Asia Pacific Maternal Fetal

Medicine Foundation